A critical advance in cancer study is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor protector protein is frequently lost in many kinds of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research